Page 2 - Containment Level News Today

Cambridge scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the virus, an approach that could be used to develop a new generation of antiviral drugs.

A new grant from the Canadian Foundation for Innovation will invest in leading-edge Containment Level 3 facilities and personnel SOURCE: RI-MUHC and McGill FMHS Sneak peak in the RI-MUHC CL3 platform

Revenues grew 32% year-over-year to $0.74 million for the quarter Clinic network revenues grew 59.5% from the same quarter last year and 7.5% compared to prior...

The health of farm animals is critical to the health of farming. Click to read more...

Information on taking, submitting and processing samples which potentially contain monkeypox virus.

Numinus Wellness Inc. (OTCPK:NUMIF) Q2 2022 Results Conference Call April 14, 2022 05:30 PM ET Company Participants Jamie Kokoska - VP, IR Payton Nyquvest - Founder and CEO John Fong - CFO...

Revenues grew 240% year-over-year to $0.8 million for the quarter Achieved 29.1% gross margin during Q2 2022, compared to 6.5% in Q1 2022, due to a larger...

FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, March 30, 2022 /PRNewswire/ -- Depression and anxiety affect millions around the world and the venom of a toad is the

/PRNewswire/ -- Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic compound being used as an alternative...

Surging COVID-19 case numbers are prompting a workplace built to handle the world’s most infec...